Beijing Airdoc’s H1 2024: Revenue Up, Net Loss Doubles
Company Announcements

Beijing Airdoc’s H1 2024: Revenue Up, Net Loss Doubles

Beijing Airdoc Technology Co. Ltd. Class H (HK:2251) has released an update.

Beijing Airdoc Technology Co. Ltd. reports a revenue increase to RMB 93,710,000 for the first half of 2024, although the firm also experienced a significant net loss of RMB 81,488,000 during the same period. The company’s unaudited financial results, reviewed by Ernst & Young, indicate a doubling in loss per share from the previous year. Despite these losses, the company still maintains a solid financial position with total equity attributable to shareholders at RMB 1,455,242,000.

For further insights into HK:2251 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App